Registration for a live webinar on 'Chronic inflammation, immune cell trafficking and anti-trafficking agents' is now open.See webinar details
Prof. Keith Martin University of Cambridge, UK1 Talk
Keith Martin was elected as the first Professor of Ophthalmology at the University of Cambridge in 2010. He is Head of Ophthalmology at the University of Cambridge, Deputy Director of the University’s John van Geest Centre for Brain Repair and an Affiliate Principal Investigator at the Wellcome Trust - MRC... read moreCambridge Stem Cell Institute. He is also Academic Lead for Ophthalmology and Lead Clinician for Glaucoma at the Cambridge University Hospitals NHS Foundation Trust. He graduated from the University of Cambridge with a 'Triple First' in Medical Sciences and Neuroscience before completing clinical Training at Oxford University Clinical School, Ophthalmology Residency in Cambridge and Clinical and Research Fellowships in Glaucoma at Moorfields Eye Hospital in London and the Wilmer Eye Institute in Baltimore. Professor Martin established and runs the Glaucoma Research Laboratory at the University of Cambridge, working to develop new treatments for eye disease using stem cells, gene therapy and other techniques. In 2010, Professor Martin won the ARVO Foundation for Eye Research Translational Research Award, an international prize to a researcher from any country under the age of 50 years whose research is judged to have the potential to lead to major breakthroughs in the treatment of eye disease. He was also a winner of the World Glaucoma Association Senior Clinician Scientist Award in 2011. Clinically, Professor Martin specialises in the medical and surgical management of complex glaucoma in adults and children. He is Basic Science Section Co-Editor of the Journal of Glaucoma and Vice-President and President Elect of the World Glaucoma Association.